| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Animals living in polluted environments are a potential source of anti-tumor molecule(s)
|
Jeyamogan, Shareni
|
|
2017
|
80 |
5 |
p. 919-924
|
article
|
| 2 |
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification
|
Moj, Daniel
|
|
2017
|
80 |
5 |
p. 1013-1026
|
article
|
| 3 |
A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)
|
Ikezawa, Yasuyuki
|
|
2017
|
80 |
5 |
p. 955-963
|
article
|
| 4 |
Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab
|
Nomura, Motoo
|
|
2017
|
80 |
5 |
p. 999-1004
|
article
|
| 5 |
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
|
Oronsky, Bryan
|
|
2017
|
80 |
5 |
p. 895-907
|
article
|
| 6 |
Inhibitory growth evaluation and apoptosis induction in MCF-7 cancer cells by new 5-aryl-2-butylthio-1,3,4-oxadiazole derivatives
|
Khanam, Rashmin
|
|
2017
|
80 |
5 |
p. 1027-1042
|
article
|
| 7 |
Innovative intraoral cooling device better tolerated and equally effective as ice cooling
|
Walladbegi, Java
|
|
2017
|
80 |
5 |
p. 965-972
|
article
|
| 8 |
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma
|
Zhou, Zhengqiu
|
|
2017
|
80 |
5 |
p. 1043-1046
|
article
|
| 9 |
miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1
|
Zhang, Haifeng
|
|
2017
|
80 |
5 |
p. 973-984
|
article
|
| 10 |
Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107
|
Sato, Kei
|
|
2017
|
80 |
5 |
p. 939-943
|
article
|
| 11 |
Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics
|
Pariente, Roberto
|
|
2017
|
80 |
5 |
p. 985-998
|
article
|
| 12 |
Phase I study of a chloroquine–gemcitabine combination in patients with metastatic or unresectable pancreatic cancer
|
Samaras, Panagiotis
|
|
2017
|
80 |
5 |
p. 1005-1012
|
article
|
| 13 |
Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
|
Kim, Kyung
|
|
2017
|
80 |
5 |
p. 945-954
|
article
|
| 14 |
Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy
|
Shi, Xingjuan
|
|
2017
|
80 |
5 |
p. 909-917
|
article
|
| 15 |
Repositioning of proton pump inhibitors in cancer therapy
|
Lu, Zhen-Ning
|
|
2017
|
80 |
5 |
p. 925-937
|
article
|
| 16 |
The potential of multi-compound nanoparticles to bypass drug resistance in cancer
|
Silva, C. G. Da
|
|
2017
|
80 |
5 |
p. 881-894
|
article
|
Journal description